Jonathan Kil
Amministratore Delegato presso Sound Pharmaceuticals, Inc.
Profilo
Jonathan Kil is the founder.
He founded Otogene in 1998 and Sound Pharmaceuticals, Inc. in 2002, where he currently holds the title of Director, Chief Executive & Medical Officer.
Dr. Kil has a doctorate degree from the University of Virginia and an undergraduate degree from the University of California, Irvine.
Posizioni attive di Jonathan Kil
| Società | Posizione | Inizio |
|---|---|---|
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Amministratore Delegato | 01/02/2002 |
Precedenti posizioni note di Jonathan Kil
| Società | Posizione | Fine |
|---|---|---|
| Otogene | Fondatore | - |
Formazione di Jonathan Kil
| University of California, Irvine | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Otogene |
- Borsa valori
- Insiders
- Jonathan Kil
